Observational Research Senior Manager (Pharmacovigilance Epidemiology, Causal Inference, Obesity)
Amgen
About this role
A Senior Manager in Observational Research at Amgen focuses on generating real-world evidence to support drug development and commercialization, particularly in the obesity therapeutic area and pharmacovigilance epidemiology/causal inference. The role involves designing and executing studies using causal inference frameworks to inform business decisions and regulatory requirements.
Skills
About Amgen
amgen.comAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Recent company news
Amgen Named to Forbes’ 2026 List of America’s Best Large Employers
2 days ago
Franklin Resources Inc. Lowers Position in Amgen Inc. $AMGN
4 hours ago
Amgen Touts 2025 Double-Digit Growth, MariTide Obesity Push and BiTE Momentum at Leerink Conference
13 hours ago
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
3 days ago
About Amgen
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Amgen.
Salary
$165k – $186k
per year
More jobs at Amgen
Similar Jobs
Post-Doc Fellow, Causal Inference
Cu
Dir, Epidemiology (SME External Control Arms)
Syneos Health
Post-Doc Fellow, Causal Inference
Cu
Post-Doc Fellow, Causal Inference
Cu
Director, Epidemiology-Health Economics & Outcomes Research
Regeneron Pharmaceuticals
Director, Real World Data & Epidemiology (RWD & EPI) Analytics
Genmab